GSK refutes consumer spin-off rumor

Share this article:

GlaxoSmithKline is not looking to offload its consumer business. Bloomberg reports that the UK drugmaker refuted a Financial Times article that indicated a spin-off was imminent.

This does not mean it could not happen—GSK  tells Bloomberg it won't turn the consumer business into a free-standing operation “in the near term.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.